BiDil — The Story of the Black Pill @NEJMgroup
BiDil — The Story of the Black Pill @NEJMgroup
Uploaded June 2026 | Updated September 2026, 1 week ago
How did a drug for congestive heart failure get approved and marketed for Black people only?



 



A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2601978.
BiDil — The Story of the Black PillImage Challenge — May 7, 2026High-Reliability Organizing: Refreshing a Proven Framework for Modern Health Care ChallengesClinical Practice: Prevention and Treatment of Peanut AllergyDr. Glaucomflecken Explains: Rituximab versus Ocrelizumab in Relapsing Multiple SclerosisCould a Low-Plastic Lifestyle Lower Plastic Levels in our Body?Three Studies That Made Headlines in MayClinical Practice: FibromyalgiaDr. Glaucomflecken Explains: Intensive LDL Cholesterol Targeting in Atherosclerotic CVD (Ez-PAVE)Clinical Problem-Solving: Too Much of a Good ThingNEJM Clinician: Are PPIs Linked to COPD Flares?Naomi T. Nkinsi, MD, MPH, on Racial Bias in Diagnosing Kidney Disease
NEJM Group |

BiDil — The Story of the Black Pill

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER